Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults
Clinical trial NCT00123968 · COMPLETED
Trial details
- NCT number
- NCT00123968
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2012-06-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.